Franklin Cudjoe, the President of policy think-tank IMANI Africa, has launched a passionate plea for the radical overhaul of neurodegenerative care in Ghana, describing the current lack of medical specialists as a national crisis.
In a move that has personalised the policy debate, Mr Cudjoe revealed that he has been diagnosed with Parkinson’s disease.
Following a high-profile one-on-one meeting with President John Dramani Mahama earlier this year, the IMANI leader is now championing the inclusion of Parkinson’s and similar conditions under the government’s flagship Mahama Cares Programme.
Central to Mr Cudjoe’s advocacy is the alarming scarcity of neurological expertise within the Ghana Health Service.
With the national population now approaching 35 million, the number of specialists available to treat brain and nerve disorders remains stagnant at about 15.
“Fifteen neurologists for a population of almost 35 million is unconscionable,” Mr Cudjoe said, noting that the paucity of trained specialists hinders proper diagnosis and treatment.
This shortage has dire consequences for patient outcomes.
Mr Cudjoe highlighted a disturbing trend where general practitioners frequently misread the hallmark symptoms of Parkinson’s.
He noted that involuntary tremors—a primary indicator of the disease—are often wrongly attributed to intoxication or drunkenness by uninformed medical staff.
This medical illiteracy, he argues, does more than just delay treatment; it destroys lives. The resulting social stigma frequently forces patients into isolation, with Mr Cudjoe revealing that some sufferers, feeling abandoned by the system, have even contemplated suicide.
The IMANI President expressed a cautious optimism that the leadership at the Ministry of Health, specifically Minister Kwabena Mintah Akandoh and Deputy Minister Grace Ayensu-Danquah, will respond to the call. The goal is two-fold:
- Mahama Cares Integration: To provide specialised support and social safety nets for those with neurodegenerative conditions.
- NHIS Expansion: To ensure that the National Health Insurance Scheme covers the high cost of life-altering medications.
Mr Cudjoe emphasised that bringing Parkinson’s “out of the shadows” is the first step toward a more humane healthcare system. By institutionalising support, the state can remove the burden from individual families who currently struggle to source rare medications through informal international supply chains.
“Creating awareness of Parkinson’s is half the battle won. Once included, patients will gain access to treatment and support without relying on personal networks or international supply chains,” Cudjoe added.
As the government evaluates its 2026 health budget, the inclusion of Parkinson’s in the ‘Mahama Cares’ framework remains a critical litmus test for the administration’s commitment to inclusive healthcare.
DISCLAIMER: The Views, Comments, Opinions, Contributions and Statements made by Readers and Contributors on this platform do not necessarily represent the views or policy of Multimedia Group Limited.
DISCLAIMER: The Views, Comments, Opinions, Contributions and Statements made by Readers and Contributors on this platform do not necessarily represent the views or policy of Multimedia Group Limited.
Source: www.myjoyonline.com